Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne

Fluorescent light energy therapy combined with low‐dose isotretinoin or tetracycline show remarkable clinical effect on 12 cases of moderate‐to‐severe acne. Treatment was considered safe, well‐tolerated, and highly efficacious.

Detalles Bibliográficos
Autores principales: Russo, Antonio, Mellergaard, Maiken, Pellacani, Giovanni, Nisticò, Steven, Nielsen, Michael Canova Engelbrecht
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077247/
https://www.ncbi.nlm.nih.gov/pubmed/33936640
http://dx.doi.org/10.1002/ccr3.3944
_version_ 1783684843633115136
author Russo, Antonio
Mellergaard, Maiken
Pellacani, Giovanni
Nisticò, Steven
Nielsen, Michael Canova Engelbrecht
author_facet Russo, Antonio
Mellergaard, Maiken
Pellacani, Giovanni
Nisticò, Steven
Nielsen, Michael Canova Engelbrecht
author_sort Russo, Antonio
collection PubMed
description Fluorescent light energy therapy combined with low‐dose isotretinoin or tetracycline show remarkable clinical effect on 12 cases of moderate‐to‐severe acne. Treatment was considered safe, well‐tolerated, and highly efficacious.
format Online
Article
Text
id pubmed-8077247
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80772472021-04-29 Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne Russo, Antonio Mellergaard, Maiken Pellacani, Giovanni Nisticò, Steven Nielsen, Michael Canova Engelbrecht Clin Case Rep Case Reports Fluorescent light energy therapy combined with low‐dose isotretinoin or tetracycline show remarkable clinical effect on 12 cases of moderate‐to‐severe acne. Treatment was considered safe, well‐tolerated, and highly efficacious. John Wiley and Sons Inc. 2021-02-20 /pmc/articles/PMC8077247/ /pubmed/33936640 http://dx.doi.org/10.1002/ccr3.3944 Text en © 2021 Klox R&D Center Guangdong Klox Biomedical Group Co., Ltd. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Russo, Antonio
Mellergaard, Maiken
Pellacani, Giovanni
Nisticò, Steven
Nielsen, Michael Canova Engelbrecht
Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
title Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
title_full Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
title_fullStr Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
title_full_unstemmed Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
title_short Fluorescent light energy combined with systemic isotretinoin: A 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
title_sort fluorescent light energy combined with systemic isotretinoin: a 52‐week follow‐up evaluating efficacy and safety in treatment of moderate‐severe acne
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077247/
https://www.ncbi.nlm.nih.gov/pubmed/33936640
http://dx.doi.org/10.1002/ccr3.3944
work_keys_str_mv AT russoantonio fluorescentlightenergycombinedwithsystemicisotretinoina52weekfollowupevaluatingefficacyandsafetyintreatmentofmoderatesevereacne
AT mellergaardmaiken fluorescentlightenergycombinedwithsystemicisotretinoina52weekfollowupevaluatingefficacyandsafetyintreatmentofmoderatesevereacne
AT pellacanigiovanni fluorescentlightenergycombinedwithsystemicisotretinoina52weekfollowupevaluatingefficacyandsafetyintreatmentofmoderatesevereacne
AT nisticosteven fluorescentlightenergycombinedwithsystemicisotretinoina52weekfollowupevaluatingefficacyandsafetyintreatmentofmoderatesevereacne
AT nielsenmichaelcanovaengelbrecht fluorescentlightenergycombinedwithsystemicisotretinoina52weekfollowupevaluatingefficacyandsafetyintreatmentofmoderatesevereacne

Ejemplares similares